FAG
CVS icon

Fortitude Advisory Group’s CVS Health CVS Stock Holding History

Fortitude Advisory Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,951
Closed -$315K – 205
2024
Q1 		$315K Sell
3,951
-260
-6% -$19.9K 0.18% 124
2023
Q4 		$333K Sell
4,211
-137
-3% -$9.75K 0.2% 113
2023
Q3 		$304K Sell
4,348
-30
-0.7% -$2.13K 0.21% 112
2023
Q2 		$303K Sell
4,378
-157
-3% -$11.2K 0.22% 111
2023
Q1 		$337K Buy
4,535
+57
+1% +$4.78K 0.26% 104
2022
Q4 		$417K Buy
4,478
+3
+0.1% +$289 0.36% 77
2022
Q3 		$427K Sell
4,475
-46
-1% -$4.55K 0.41% 63
2022
Q2 		$419K Buy
4,521
+269
+6% +$26.3K 0.38% 71
2022
Q1 		$430K Buy
4,252
+268
+7% +$28.2K 0.23% 77
2021
Q4 		$411K Buy
+3,984
New +$368K 0.21% 89

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fortitude Advisory Group's CVS Position: Q2 2024 in Review

Fortitude Advisory Group sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,951 shares — an estimated $315K sold.

Fortitude Advisory Group first reported a position in CVS in Q4 2021 and held it in 10 quarters. The position peaked at $430K in Q1 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Fortitude Advisory Group reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Fortitude Advisory Group sold 3,951 CVS Health shares in Q2 2024, an estimated $315K.
  • Fortitude Advisory Group first reported a position in CVS Health in Q4 2021 and held it in 10 quarters.
  • Fortitude Advisory Group's CVS Health position peaked at $430K in Q1 2022.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Fortitude Advisory Group's 13F filing for Q2 2024, filed 25 Jul 2024.